Walleye Capital LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-06 3:08 pm Unchanged | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Walleye Capital LLC | 5,000,000 4.820% | 0 (Unchanged) | Filing |
| 2024-11-13 4:52 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Walleye Capital LLC | 5,000,000 5.300% | 5,000,000 (New Position) | Filing |